So, gefitinib is like a little block for something called the Epidermal Growth Factor Receptor, which is a bit of a big deal in NSCLC. It’s used when someone has this specific type of mutation, like the ones in exons 19 or 21, known as L858R. It comes in tablet form, sort of like a little film-coated pill, and they’re 250 mg each.
You’re usually supposed to take these tablets once a day, and it doesn’t matter if you eat or not. These tablets come in bottles, each bottle has about 30 of them. Gefitinib kind of blocks this signaling pathway stuff, and that slows down the cancer cell growth.
You got to keep an eye on this under a doctor’s watch and only take it like your healthcare pro tells you to.
